Ginkgo bioworks announces participation in the 43rd annual j.p. morgan healthcare conference

Boston , jan. 9, 2025 /prnewswire/ -- ginkgo bioworks (nyse: dna), which is building the leading platform for cell programming and biosecurity, today announced that co-founder and ceo, jason kelly, is scheduled to present at the 43rd annual j.p. morgan healthcare conference on thursday, january 16, 2025 at 10:30 a.m.

DNA Ratings Summary

DNA Quant Ranking